Abstract
In the development of promising, safe and effective vaccines, different approaches are recruited, such as the employment of inactivated and/or attenuated virus, the use of virus-like particles (VLPs), and the incorporation of antigens into nanostructured silicas. VLPs are widely accepted because the immune system responds to them in a similar way to the response against vaccines of inacti…